SCHEMBL18398581

SCHEMBL18398581

CCc1cc(C#N)ccc1Nc1cc2c(ncn2C)c(NC(=O)C2CC2)n1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 4/20 0.53
▸ JAK1 P23458 4/20 0.53
▸ TYK2 P29597 4/20 0.53
▸ JAK3 P52333 4/20 0.53
▸ ABL1 P00519 1/20 0.39
▸ GNRHR P30968 1/20 0.37
▸ EGLN2 Q96KS0 4/20 0.36
▸ GSK3B P49841 3/20 0.36
▸ DYRK1A Q13627 2/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ BRAF P15056 1/20 0.35
▸ TBK1 Q9UHD2 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ PIK3C3 Q8NEB9 1/20 0.35
▸ WNT1 P04628 1/20 0.35
▸ TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409176 0.91 TYK2 (0.48) JAK2JAK1TYK2JAK3ABL1
SCHEMBL18409205 0.88 JAK2 (0.40) JAK2JAK1TYK2JAK3EGLN2
SCHEMBL18409114 0.87 TYK2 (0.46) JAK2JAK1TYK2JAK3ABL1
SCHEMBL18409287 0.86 JAK2 (0.47) JAK2JAK1TYK2JAK3ABL1
SCHEMBL18409202 0.85 TYK2 (0.53) JAK2JAK1TYK2JAK3ABL1
SCHEMBL18409285 0.85 TYK2 (0.62) JAK2JAK1TYK2JAK3ABL1
SCHEMBL18409158 0.83 TYK2 (0.58) JAK2JAK1TYK2JAK3ABL1
SCHEMBL18409133 0.82 TYK2 (0.42) JAK2JAK1TYK2JAK3ABL1
SCHEMBL18409365 0.81 GSK3B (0.44) JAK2JAK1TYK2JAK3GSK3B
SCHEMBL18409117 0.79 TYK2 (0.55) JAK2JAK1TYK2JAK3ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback